financetom
Business
financetom
/
Business
/
Update: AST SpaceMobile to Advance Plan to Access Lower Mid-Band Spectrum in North America; Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: AST SpaceMobile to Advance Plan to Access Lower Mid-Band Spectrum in North America; Shares Rise
Jun 13, 2025 7:06 AM

09:58 AM EDT, 06/13/2025 (MT Newswires) -- (Updates to include the stock movement in the headline and first paragraph.)

AST SpaceMobile ( ASTS ) shares rose as much as 11.4% in recent Friday trading after the company said it has signed a settlement term sheet to advance its plan for long-term access to up to 45 megahertz of premium lower mid-band spectrum in the US and Canada for direct-to-device satellite applications.

The term sheet states that Inmarsat Global will support AST in obtaining long-term spectrum usage rights for 80 or more years held by Ligado Networks, as well as its planned regulatory applications in the US and Canada, AST said.

Ligado will receive $550 million upon the closing of the deal, with $535 million going to Inmarsat, AST said.

AST said it has secured a $550 million institutional financing commitment to support this consideration.

The term sheet supplements the definitive documentation entered into by AST and Ligado in March and is subject to court approval, which is expected before the end of this month, AST said.

Price: 40.03, Change: +3.11, Percent Change: +8.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab
Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab
Oct 17, 2024
08:06 AM EDT, 10/17/2024 (MT Newswires) -- Theratechnologies ( THTX ) on Thursday announced the study design and baseline characteristics of participants in a prospective observational study of multidrug-resistant patient outcomes with and without the company's ibalizumab in a real-world setting in the U.S. (PROMISE-US). The study seeks to fill a gap in long-term clinical outcomes for heavily treatment-experienced people...
Wipro's Fiscal Q2 Earnings Rise, Revenue Falls
Wipro's Fiscal Q2 Earnings Rise, Revenue Falls
Oct 17, 2024
08:05 AM EDT, 10/17/2024 (MT Newswires) -- Wipro ( WIT ) reported fiscal Q2 earnings Thursday of 6.12 Indian rupees ($0.07) per diluted share, up from 5.04 Indian rupees a year earlier. One analyst polled by Capital IQ expected 5.55 Indian rupees. Revenue for the quarter ended Sept. 30 was 223.02 billion Indian rupees compared with 225.16 billion Indian rupees...
Market Chatter: Couche-Tard Executives Make Case to Buy Seven & i in Tokyo
Market Chatter: Couche-Tard Executives Make Case to Buy Seven & i in Tokyo
Oct 17, 2024
08:09 AM EDT, 10/17/2024 (MT Newswires) -- Alimentation Couche-Tard Inc.'s ( ANCTF ) founder and top executives are spending three days in Tokyo this week, seeking to make their case for buying Seven & i Holdings Co. for about 7.1 trillion yen ($47.4 billion) despite being rebuffed by the Japanese retailer, Bloomberg News is reporting. The report noted Couche-Tard is...
Marsh McLennan beats profit estimates on risk and insurance unit strength
Marsh McLennan beats profit estimates on risk and insurance unit strength
Oct 17, 2024
Oct 17 (Reuters) - Insurance brokerage Marsh McLennan ( MMC ) reported a better-than-expected profit for the third quarter on Thursday, bolstered by its risk and insurance services business. WHY IT'S IMPORTANT Rising wages and growing expectations of a soft landing for the U.S. economy have prompted individuals and companies across various sectors to spend more on insurance policies despite...
Copyright 2023-2026 - www.financetom.com All Rights Reserved